<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Varady A</submitter><funding>Österreichische Forschungsförderungsgesellschaft</funding><funding>Austrian Science Fund FWF</funding><funding>Alex's Lemonade Stand Foundation for Childhood Cancer</funding><funding>Österreichischen Akademie der Wissenschaften</funding><funding>St. Anna Children's Cancer Research Institute</funding><pagination>DMM052016</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11892682</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(2)</volume><pubmed_abstract>Owing to their high efficacy, antimitotic chemotherapeutics are the mainstay for most cancer treatments. However, these drugs do not discriminate between tumor and healthy cells, thus show dose-limiting toxicity and severe adverse effects. To improve treatments, rendering chemotherapeutics tumor-cell specific is highly desirable. Although various strategies, such as targeted antibody-drug conjugates, aim to achieve this goal, the identification of a tumor-specific 'Achilles' heel' remains a challenge. Here, we followed an alternative approach, which does not rely on tumor-specific characteristics, but rather uses spatially confined illumination of the light-activatable microtubule inhibitor SBTubA4P to target its cytotoxic activity to tumor cells. We demonstrate that localized illumination</pubmed_abstract><journal>Disease models &amp; mechanisms</journal><pubmed_title>Precise photopharmacological eradication of metastatic tumor cells.</pubmed_title><pmcid>PMC11892682</pmcid><funding_grant_id>7940628</funding_grant_id><funding_grant_id>20-17258</funding_grant_id><funding_grant_id>P30038-BBL</funding_grant_id><pubmed_authors>Varady A</pubmed_authors><pubmed_authors>Schmitner N</pubmed_authors><pubmed_authors>Poplimont H</pubmed_authors><pubmed_authors>Sturtzel C</pubmed_authors><pubmed_authors>Gao L</pubmed_authors><pubmed_authors>Distel M</pubmed_authors><pubmed_authors>Kimmel RA</pubmed_authors><pubmed_authors>Grissenberger S</pubmed_authors><pubmed_authors>Wenninger-Weinzierl A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Precise photopharmacological eradication of metastatic tumor cells.</name><description>Owing to their high efficacy, antimitotic chemotherapeutics are the mainstay for most cancer treatments. However, these drugs do not discriminate between tumor and healthy cells, thus show dose-limiting toxicity and severe adverse effects. To improve treatments, rendering chemotherapeutics tumor-cell specific is highly desirable. Although various strategies, such as targeted antibody-drug conjugates, aim to achieve this goal, the identification of a tumor-specific 'Achilles' heel' remains a challenge. Here, we followed an alternative approach, which does not rely on tumor-specific characteristics, but rather uses spatially confined illumination of the light-activatable microtubule inhibitor SBTubA4P to target its cytotoxic activity to tumor cells. We demonstrate that localized illumination</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2026-05-29T12:46:29.662Z</modification><creation>2025-04-05T23:53:16.938Z</creation></dates><accession>S-EPMC11892682</accession><cross_references><pubmed>40014051</pubmed><doi>10.1242/dmm.052016</doi></cross_references></HashMap>